AxoGen Announces Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float

World News: . []

ALACHUA, Fla., Dec. 06, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that Madelyn Nicpon was selected to ride on the 2019 Donate Life Rose Parade float that will be featured in the annual Tournament of Roses parade. The parade takes place in Pasadena on New Year’s Day.

Madelyn (Madie) was a sophomore in high school when she underwent routine dental surgery to remove her wisdom teeth. Several days later, however, the right side of her tongue remained numb. Madie and her parents soon learned that the persistent numbness in her tongue was the result of damage to her lingual nerve – the nerve that provides sensation to the tongue. The nerve had been damaged during the procedure to remove her wisdom teeth. Madie, an outgoing and athletic honor student was having difficulty speaking and was repeatedly biting her tongue while eating.

Damaged peripheral nerves can be surgically repaired, but the window of time for effective outcomes is limited, so expertise from a nerve specialist must be sought quickly. Fortunately, the Nicpon family found Dr. Vincent Ziccardi, an oral surgeon skilled in microsurgery and nerve repair. Dr. Ziccardi repaired Madie’s damaged lingual nerve with Avance® Nerve Graft which allowed her lingual nerve to regenerate, restoring sensation to her tongue. She is back to organizing class activities and playing competitive lacrosse.

Avance Nerve Graft is an off the shelf processed human nerve allograft intended for the surgical repair of peripheral nerve discontinuities. Nerve damage can result in loss of sensation or movement and reduced quality of life. AxoGen is dedicated to transforming nerve repair by providing innovative solutions to surgeons and their patients.

“If it weren’t for Dr. Ziccardi and the generosity of a nerve tissue donor I may be living with the challenges of a partially numb tongue for the rest of my life,” said Madie. “I encourage everyone to become a tissue and organ donor and am grateful for the opportunity to share my personal story by participating as a rider on the Donate Life Rose Parade float.” Madie’s participation in the parade is sponsored by AxoGen Corporation.

“Nearly a million Americans undergo surgical procedures to repair peripheral nerve damage every year,” said Karen Zaderej, chairman, CEO, and president of AxoGen. “There are many causes of peripheral nerve damage – from accidents, to severe cuts, to damage resulting from surgical procedures. We recognize that our ability to provide Avance® Nerve Graft to patients like Madie is made possible through the gift of donated tissue and the work of organizations such as Donate Life.”

Madie will ride alongside 17 other organ, eye, or tissue recipients, honoring their donors. The Donate Life Rose Parade float is the centerpiece of a national effort of more than 50 organizations to reach a broad audience with the simple, life-giving message that organ, eye, and tissue donation saves and improves lives.

AxoGen's platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site, AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves, AxoGuard Nerve Protector, a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments, and Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that may be used as a resorbable soft tissue covering to separate tissue layers and modulate inflammation in the surgical bed. Along with these core surgical products, AxoGen also offers AcroVal Neurosensory & Motor Testing System and AxoTouch Two-Point Discriminator. These evaluation and measurement tools assist health care professionals in detecting changes in sensation, assessing return of sensory, grip, and pinch function, evaluating effective treatment interventions, and providing feedback to patients on peripheral nerve function. The AxoGen portfolio of products is available in the United States, Canada, the United Kingdom, and several other European and international countries.

AxoGen Corporation Kaila Krum, VP, Investor Relations and Corporate Development

Annette Ruzicka, Corporate Communications

More news and information about AxoGen, Inc.

Published By:

Globe Newswire: 12:00 GMT Thursday 6th December 2018

Published: .

Search for other references to "axogen" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us